Literature DB >> 16437714

Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice.

Toshiyuki Otsuka1, Norio Horiguchi, Daisuke Kanda, Takashi Kosone, Yuichi Yamazaki, Kazuhisa Yuasa, Naondo Sohara, Satoru Kakizaki, Ken Sato, Hitoshi Takagi, Glenn Merlino, Masatomo Mori.   

Abstract

AIM: To investigate the in vivo effects of NK2 on liver regeneration after partial hepatectomy (PH).
METHODS: Survival after PH was observed with 21 NK2 transgenic mice and 23 wild-type (WT) mice over 10 d. Liver regeneration was analyzed using histology and immunohistochemistry. Expressions of genes were analyzed using Northern blot analysis, immunoprecipitation and immunoblotting, and reverse transcriptase polymerase chain reaction assay. Kaplan-Meier method and the log-rank test were used for analyzing the survival after PH. Differences in the results of immunohistochemistry and percentage of liver regeneration was determined by the Student's t-test.
RESULTS: More than half of NK2 transgenic mice died within 48 h after PH. After PH, increased deposition of small lipid droplets in hepatocytes was evident and hepatic proliferation was inhibited in NK2 transgenic mice. The hepatic expression and kinase activity of HGF receptor, c-Met, were unchanged among WT mice and NK2 transgenic mice after PH. The expression of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in liver tissues were prolonged in NK2 transgenic mice that died after PH.
CONCLUSION: Our findings indicate that over-expression of NK2 inhibits liver regeneration after PH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437714      PMCID: PMC4725174          DOI: 10.3748/wjg.v11.i47.7444

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

2.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

Authors:  Y Yamada; I Kirillova; J J Peschon; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.

Authors:  R Montesano; J V Soriano; K M Malinda; M L Ponce; A Bafico; H K Kleinman; D P Bottaro; S A Aaronson
Journal:  Cell Growth Differ       Date:  1998-05

4.  Generation of a mouse expressing a conditional knockout of the hepatocyte growth factor gene: demonstration of impaired liver regeneration.

Authors:  Daniel Phaneuf; A David Moscioni; Cynthia LeClair; Steven E Raper; James M Wilson
Journal:  DNA Cell Biol       Date:  2004-09       Impact factor: 3.311

5.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair.

Authors:  Chang-Goo Huh; Valentina M Factor; Aránzazu Sánchez; Koichi Uchida; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

6.  Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice.

Authors:  R D Palmiter; E P Sandgren; D M Koeller; R L Brinster
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice.

Authors:  E M Webber; J C Wu; L Wang; G Merlino; N Fausto
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

8.  Scatter factor/hepatocyte growth factor is essential for liver development.

Authors:  C Schmidt; F Bladt; S Goedecke; V Brinkmann; W Zschiesche; M Sharpe; E Gherardi; C Birchmeier
Journal:  Nature       Date:  1995-02-23       Impact factor: 49.962

9.  Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression.

Authors:  G Shiota; T C Wang; T Nakamura; E V Schmidt
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

10.  Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor.

Authors:  Y Yamada; E M Webber; I Kirillova; J J Peschon; N Fausto
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

View more
  5 in total

Review 1.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 2.  Targeting the HGF/Met signalling pathway in cancer.

Authors:  Fabiola Cecchi; Daniel C Rabe; Donald P Bottaro
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

3.  The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer.

Authors:  Fabiola Cecchi; Daniel C Rabe; Donald P Bottaro
Journal:  Curr Signal Transduct Ther       Date:  2011

Review 4.  Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.

Authors:  Ognoon Mungunsukh; Elizabeth A McCart; Regina M Day
Journal:  Biomedicines       Date:  2014-11-05

Review 5.  [Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

Authors:  Yongwen Li; Hongyu Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.